Listar CAT - Articles científics por fecha de publicación

The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction

Tintore, Mar; Alexander, Maggie; Costello, Kathleen; Duddy, Martin; Jones, David E; Law, Nancy (Dove Medical Press, 2016-12-22)

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

Link, Jenny; Ramanujam, Ryan; Auer, Michael; Ryner, Malin; Hassler, Signe; Bachelet, Delphine; Montalban, Xavier; Comabella Lopez, Manuel; Fissolo, Nicolás Miguel (Public Library of Science, 2017-02-07)

Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome

Makhani, Naila; Lebrun, Christine; Siva, Aksel; Narula, Sona; Wassmer, Evangeline; Brassat, David; Tintore, Mar (SAGE Publications, 2019-03-20)

Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care

Saposnik, Gustavo; Mamdani, Muhammad; Montalban, Xavier; Terzaghi, Maria A; Silva, Berenice; Saladino, Maria Laura (SAGE Publications, 2019-06-21)

Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study

Midaglia Fernandez, Luciana; Mulero Carrillo, Patricia; Montalban, Xavier; Graves, Jennifer; Hauser, Stephen L.; Julian, Laura (JMIR Publications, 2019-08-30)

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis: a longitudinal OCT study

Balk, Lisanne J; Coric, Danko; Knier, Benjamin; Zimmermann, Hanna G; Behbehani, Raed; Alroughani, Raed; Vidal Jordana, Angela; Montalban, Xavier (SAGE Publications, 2019-09-05)

Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies

Ruiz de Morales, José María G.; Puig, Lluís; Daudén, Esteban; Cañete, Juan D.; Pablos, José Luis; Olveira Martín, Antonio; Montalban, Xavier; Borruel Sainz, Natalia; Orti Pascual, Guillem (Elsevier, 2020-01)

Codisseny d’una eina web per fomentar les decisions compartides en persones amb esclerosi múltiple

Robles-Sánchez, Miguel Ángel; Moharra, Montse (Acadèmia de Ciències Mèdiques i de la Salut de Catalunya i de Balears, 2020-04)

Recomendaciones para la vacunación en pacientes con esclerosis múltiple candidatos a terapias inmunosupresoras: documento de consenso español

Otero Romero, Susana; Rodríguez-García, J.; Vilella, A.; Brieva Ruiz, Luis; Calles, C.; Tintore, Mar; Ara Callizo, José Ramón (Elsevier, 2021-01)

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders

Pinteac, Rucsanda; Montalban, Xavier; Comabella Lopez, Manuel (Lippincott Williams & Wilkins, 2021-01)

A R-Script for Generating Multiple Sclerosis Lesion Pattern Discrimination Plots

Marschallinger, Robert; Tur Gomez, Carmen; Marschallinger, Hannes; Sellner, Johann (MDPI, 2021-01-12)

Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS

DeLuca, John; Schippling, Sven; Montalban, Xavier; Comi, Giancarlo; Kappos, Ludwig; Cree, Bruce (Elsevier, 2021-02)

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS

Matute Blanch, Clara; Osman, Mohamoud; Costa Riu, Carme; Pinteac, Rucsanda; Miró Cau, Berta; Sánchez Pla, Alex; Brito, Veronica Ines; Montalban, Xavier; Comabella Lopez, Manuel; Fissolo, Nicolás Miguel (Wolters Kluwer Health, 2021-03)

Deciphering Multiple Sclerosis Progression

Berenguer-Ruiz, Leticia; Carreres-Polo, Joan; Eichau-Madueño, Sara; Ferrer-Lozano, Jaime; Forero, Lucía; Vidal Jordana, Angela; Meca-Lallana, Virginia (Frontiers Media, 2021-04)

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease

Geraldes, Ruth; Juryńczyk, Maciej; Passos, Giordani; Pichler, Alexander; Hagens, Marloes; Auger Acosta, Cristina; Rovira, Alex; Sastre Garriga, Jaume; Chung, Karen (SAGE Publications, 2021-05)

Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program

Selmaj, Krzysztof W.; Cohen, Jeffrey A; Comi, Giancarlo; Arnold, Douglas L; Steinman, Lawrence; Montalban, Xavier; Bar-Or, Amit (Elsevier, 2021-06)

Angiogenin in the Neurogenic Subventricular Zone After Stroke

Gabriel Salazar, Marina; Lei (Santiago), Ting; Grayston Morales, Alba; Costa Riu, Carme; Medina Gutierrez, Esperanza; Montaner Villalonga, Joan; Rosell Novel, Anna; Comabella Lopez, Manuel (Frontiers Media, 2021-06-21)

SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry

Arrambide, Georgina; Llaneza González, Miguel Ángel; Fernández-Díaz, Eva; Moreno Torres, Irene; Meca-Lallana, Virginia; Costa-Frossard França, Lucienne (Lippincott Williams & Wilkins, 2021-06-24)

Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom

Abdel-Mannan, Omar; Manchoon, Celeste; Rossor, Thomas; Southin, Justine-Clair; TUR, CARMEN; Brownlee, Wallace (Lippincott Williams & Wilkins, 2021-07)

Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis

Picón, Carmen; Tejeda-Velarde, Amalia; Fernández-Velasco, José Ignacio; Álvarez-Lafuente, Roberto; Quintana, Ester; Matute Blanch, Clara; Espejo Ruiz, Carmen; Comabella Lopez, Manuel (Frontiers Media, 2021-07)

Scientia. Depósito de Información Digital del Departamento de Salud

Listar CEMCAT - Articles científics por fecha de publicación

The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome

Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care

Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis: a longitudinal OCT study

Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies

Codisseny d’una eina web per fomentar les decisions compartides en persones amb esclerosi múltiple

Recomendaciones para la vacunación en pacientes con esclerosis múltiple candidatos a terapias inmunosupresoras: documento de consenso español

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders

A R-Script for Generating Multiple Sclerosis Lesion Pattern Discrimination Plots

Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS

Deciphering Multiple Sclerosis Progression

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease

Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program

Angiogenin in the Neurogenic Subventricular Zone After Stroke

SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry

Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom

Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis

Scientia. Depósito de Información Digital del Departamento de Salud

Listar CEMCAT - Articles científics por fecha de publicación

The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction ﻿

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results ﻿

Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome ﻿

Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care ﻿

Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study ﻿

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis: a longitudinal OCT study ﻿

Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies ﻿

Codisseny d’una eina web per fomentar les decisions compartides en persones amb esclerosi múltiple ﻿

Recomendaciones para la vacunación en pacientes con esclerosis múltiple candidatos a terapias inmunosupresoras: documento de consenso español ﻿

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders ﻿

A R-Script for Generating Multiple Sclerosis Lesion Pattern Discrimination Plots ﻿

Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS ﻿

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS ﻿

Deciphering Multiple Sclerosis Progression ﻿

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease ﻿

Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program ﻿

Angiogenin in the Neurogenic Subventricular Zone After Stroke ﻿

SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry ﻿

Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom ﻿

Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis ﻿

The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome

Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care

Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis: a longitudinal OCT study

Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies

Codisseny d’una eina web per fomentar les decisions compartides en persones amb esclerosi múltiple

Recomendaciones para la vacunación en pacientes con esclerosis múltiple candidatos a terapias inmunosupresoras: documento de consenso español

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders

A R-Script for Generating Multiple Sclerosis Lesion Pattern Discrimination Plots

Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS

Deciphering Multiple Sclerosis Progression

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease

Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program

Angiogenin in the Neurogenic Subventricular Zone After Stroke

SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry

Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom

Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis